Regulatory Science Symposium: Diversity in Clinical Trials in the Time of COVID-19 Session 6: Populations on the Fringe of Clinical Trial Enrollment
Study Design
Clinical Trials
Diversity
Inclusion
Barriers to Patient Access
Disparities in Research
Vulnerable Populations
Representation
Subject Eligibility Criteria
Regulatory Science Symposium: Diversity in Clinical Trials in the Time of COVID-19 Session 4: Clinical Trials Participation: Understanding the Needs and Importance of Diverse Populations
Technology
Clinical Research
Inclusion
Barriers to Patient Access
Surveys
Patient-Reported Outcomes
Patient-Focused Care
Dissemination of Information
Marketing Strategies